---
title: Northway Biotech vs Richter BioLogics
slug_a: northway-biotech
slug_b: richterbiologics
site: cdmo
review_signal_gate: closed
canonical_path: /compare/northway-biotech/richterbiologics
---

# Northway Biotech vs Richter BioLogics

Side-by-side profile data from each company listing on this directory.

## Northway Biotech

- Profile: [/companies/northway-biotech](/companies/northway-biotech)

Northway Biotech — End-to-end CDMO specializing in protein-based biologics and gene therapies, with 20+ years of expertise and cGMP facilities in Lithuania and Massachusetts supporting development from preclinical to commercial stages.

Services: 11. Modalities: 2. Indications: 1. Locations: 2. Certifications: 0. The strongest documented coverage currently appears in services (11).

### Services

- Biologics Development & Manufacturing
- Recombinant Protein Manufacturing
- Cell-Line Development
- Upstream Processing
- Downstream Processing
- Process Development
- Formulation Development
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage
- CMC Regulatory Submission Support

### Modalities

- Biologics (Other)
- Gene Therapy

### Development capabilities

- Analytical method development
- Formulation development
- ICH stability testing
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Expression: Mammalian
- Expression: Microbial

## Richter BioLogics

- Profile: [/companies/richterbiologics](/companies/richterbiologics)

Richter BioLogics — Germany-based CDMO specializing in GMP-compliant microbial production of recombinant proteins, peptides, plasmid DNA, and bacterial vaccines with bioreactor capacity up to 1,500 litres and regulatory clearance from FDA, EMA, ANVISA, PMDA, and MFDS.

Services: 9. Modalities: 3. Indications: 0. Locations: 1. Certifications: 4. The strongest documented coverage currently appears in services (9).

### Services

- Recombinant Protein Manufacturing
- Upstream Processing
- Downstream Processing
- Microbial Fermentation
- Peptide Manufacturing
- Vaccine Manufacturing
- Process Development
- CMC Analytical Development
- Quality Control Testing

### Modalities

- Biologics (Other)
- Peptide
- Vaccine

### Development capabilities

- Analytical method development

### Manufacturing capabilities

- Drug Substance (DS)
- Max bioreactor: Mid-scale clinical (≤2,000 L)
- Expression: Microbial